HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced in vivo antitumor efficacy of doxorubicin encapsulated within laponite nanodisks.

Abstract
Development of various nanoscale drug carriers for enhanced antitumor therapy still remains a great challenge. In this study, laponite (LAP) nanodisks encapsulated with anticancer drug doxorubicin (DOX) at an exceptionally high loading efficiency (98.3 ± 0.77%) were used for tumor therapy applications. The long-term in vivo antitumor efficacy and toxicology of the prepared LAP/DOX complexes were analyzed using a tumor-bearing mouse model. Long-term tumor appearance, normalized tumor volume, CD31 staining, and hematoxylin and eosin (H&E)-stained tumor sections were used to evaluate the tumor therapy efficacy, while long-term animal body weight changes and H&E-stained tissue sections of different major organs were used to evaluate the toxicology of LAP/DOX complexes. Finally, the in vivo biodistribution of magnesium ions and DOX in different organs was analyzed. We showed that under the same DOX concentration, LAP/DOX complexes displayed enhanced tumor inhibition efficacy and afforded the treated mice with dramatically prolonged survival time. In vivo biodistribution data revealed that the reticuloendothelial systems (especially liver) had significantly higher magnesium uptake than other major organs, and the LAP carrier was able to be cleared out of the body at 45 days post treatment. Furthermore, LAP/DOX afforded a higher DOX uptake in the tumor region than free DOX, presumably due to the known enhanced permeability and retention effect. The developed LAP-based drug delivery system with an exceptionally high DOX payload, enhanced in vivo antitumor efficacy, and low systemic toxicity may be used as a promising platform for enhanced tumor therapy.
AuthorsKai Li, Shige Wang, Shihui Wen, Yueqin Tang, Jipeng Li, Xiangyang Shi, Qinghua Zhao
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 6 Issue 15 Pg. 12328-34 (Aug 13 2014) ISSN: 1944-8252 [Electronic] United States
PMID25000274 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Silicates
  • Doxorubicin
  • laponite
Topics
  • Animals
  • Cell Line
  • Cell Proliferation (drug effects)
  • Doxorubicin (pharmacology)
  • Female
  • Humans
  • Immunohistochemistry
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (chemistry, ultrastructure)
  • Platelet Endothelial Cell Adhesion Molecule-1 (metabolism)
  • Silicates (chemistry)
  • Survival Analysis
  • Tissue Distribution (drug effects)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: